Cleaning Validation and Health-Based Exposure Limits: Carry-Over Limits You Can Defend

Cleaning validation used to rest on rules of thumb. Today the carry-over limit has to be justified by toxicology, and the evidence for that justification has to be on file.

The regulatory basis

Annex 15 requires cleaning validation to confirm the effectiveness of any cleaning procedure for product contact equipment, and states that limits for the carry-over of product residues should be based on a toxicological evaluation. The EMA guideline on setting health-based exposure limits for use in risk identification in the manufacture of different medicinal products in shared facilities took effect on 1 June 2015, with phase-in periods for existing products. It sets out how a permitted daily exposure (PDE) is derived and documented.

What a PDE assessment involves

  • hazard identification and a comprehensive literature search, with the strategy recorded;
  • identification of the critical effect and a no-observed-adverse-effect level or equivalent;
  • justified adjustment factors;
  • expert review of the assessment, with the expert’s details and date documented.

Chapter 3 of the GMP Guide also makes clear that dedicated facilities may be required where risk cannot be controlled, including where residue limits derived from toxicology cannot be reliably determined by a validated analytical method.

Annex 15 expectations for the study

  • Visual inspection is needed but is not generally acceptable as the sole criterion.
  • Repeated cleaning and retesting until acceptable results are obtained is not an acceptable approach.
  • Worst case: variable factors such as operators and rinse times should be identified, and worst-case situations used as the basis for the studies.
  • Sampling and recovery: recovery should be demonstrated from all product contact materials using the sampling methods chosen, and analytical methods must be validated.
  • Hold times: dirty and clean equipment hold times should be defined.

Beyond the first validation

Cleaning validation is not finished once the protocol passes. Changes to products, formulations, equipment or cleaning agents should be assessed through change control, and PDEs should be reviewed when new toxicological data emerge. A periodic review of cleaning performance, including routine monitoring where appropriate, should confirm that the validated state is maintained.

Frequent findings

  • Limits based on historical dose or ppm criteria with no toxicological justification on file.
  • PDE reports without a documented literature search or expert review.
  • Worst-case products chosen without a documented rationale.

A short self-check

  • Does every product in the cleaning matrix have a documented PDE or equivalent toxicological justification?
  • Are recovery studies available for each surface and sampling method?
  • Are dirty and clean hold times defined and verified?

How PQRA helps

PQRA supports sites in building cleaning validation master plans, matrix and worst-case rationales, protocols and reports, and in coordinating PDE assessments with qualified toxicological experts. We also review existing cleaning validation files against Annex 15 and the shared-facilities guideline.

Contact PQRA to discuss how we can support your quality system.

CATEGORIES:

Uncategorized

Tags:

No responses yet

Leave a Reply

Your email address will not be published. Required fields are marked *